Qu, F, et al.
Genotypes and antimicrobial profiles of Shigella sonnei isolates from diarrheal patients circulating in Beijing between 2002 and 2007. Diagnostic Microbiology and Infectious Disease
2012; 74: 166–170.
Filliol-Toutain, I, et al.
Global distribution of Shigella sonnei clones. Emerging Infectious Diseases
2011; 17: 1910–1912.
Chang, Z, et al.
Causative species and serotypes of shigellosis in Mainland China: systematic review and meta-analysis. PLoS ONE
2012; 7: e52515.
Martínez-Martínez, L, Pascual, A, Jacoby, GA. Quinolone resistance from a transferable plasmid. The Lancet
1998; 351: 797–799.
Clinical and Laboratory Standards Institute. Methods for Dilution and Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 9th edn. Approved standard M07-A9. Wayne, PA: Clinical and Laboratory Standards Institute, 2012.
Shen, Y, et al.
High prevalence of antibiotic resistance and molecular characterization of integrons among Shigella Isolates in Eastern China. Antimicrobial Agents and Chemotherapy
2013; 57: 1549–1551.
Rahman, M, et al.
Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrobial Agents and Chemotherapy
1994; 38: 2488–2491.
Chau, TT, et al.
Antimicrobial drug resistance of Salmonella enterica serovar typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrobial Agents and Chemotherapy
2007; 51: 4315–4323.
Dutta, S, et al.
Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in Quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India. Antimicrobial Agents and Chemotherapy
2005; 49: 1660–1661.
Yang, H, et al.
Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008. International Journal of Antimicrobial Agents
2013; 42: 173–177.
Hirose, K, et al.
Antimicrobial susceptibility of Shigella sonnei isolates in Japan and molecular analysis of S. sonnei isolates with reduced susceptibility to fluoroquinolones. Antimicrobial Agents and Chemotherapy
2005; 49: 1203–1205.
Qin, T, et al.
Novel mutations in quinolone resistance-determining regions of gyrA, gyrB, parC and parE in Shigella flexneri clinical isolates from eastern Chinese populations between 2001 and 2011. European Journal of Clinical Microbiology & Infectious Diseases
2016; 35: 2037–2045.
Folster, JP, et al.
Decreased susceptibility to ciprofloxacin among Shigella isolates in the United States, 2006 to 2009. Antimicrobial Agents and Chemotherapy
2011; 55: 1758–1760.
Pu, X, et al.
Quinolone resistance-determining region mutations and the plasmid-mediated quinolone resistance gene qnrS played important roles in decreased susceptibility to fluoroquinolones among Shigella isolates in southeast China between 1998 and 2013. International Journal of Antimicrobial Agents
2015; 45: 438–439.
Robicsek, A, et al.
qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrobial Agents and Chemotherapy
2006; 50: 2872–2874.
Wang, M, et al.
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis
. Antimicrobial Agents and Chemotherapy
2009; 53: 1892–1897.
Cavaco, LM, et al.
qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrobial Agents and Chemotherapy
2009; 53: 603–608.
Pu, XY, et al.
Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China. The Journal of Antimicrobial Chemotherapy
2009; 63: 917–920.
Yamane, K, et al.
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrobial Agents and Chemotherapy
2008; 52: 1564–1566.
Xiong, Z, et al.
Prevalence of plasmid-mediated quinolone-resistance determinants in Shigella flexneri isolates from Anhui Province, China. The Journal of Antibiotics
2010; 63: 187–189.